Cancer Research Aziza Shad  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 2522-2526, June 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, J.
Right arrow Articles by Swenberg, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, J.
Right arrow Articles by Swenberg, J. A.
[Cancer Research 59, 2522-2526, June 1, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Endogenous Apurinic/Apyrimidinic Sites in Genomic DNA of Mammalian Tissues1

Jun Nakamura and James A. Swenberg2

Department of Environmental Sciences and Engineering, The University of North Carolina, Chapel Hill, North Carolina 27599


    ABSTRACT
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 
Apurinic/apyrimidinic (AP) sites are one of the most frequent lesions in DNA. Using a highly sensitive slot blot assay, we determined the number and condition of endogenous AP sites in normal tissues of rats and human liver. The number of AP sites (50,000–200,000 per mammalian cell) was greatest in brain, followed by colon and heart, and then liver, lung, and kidney. The majority of endogenous AP sites were cleaved 5' to the AP site. These data suggest that removal of the deoxyribosyl phosphate moiety is the rate-limiting step in base excision and AP site repair in vivo.


    Introduction
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 
Cellular DNA is continuously exposed to insults from exposure to endogenous and exogenous alkylating agents, ionizing radiation, and oxidative stress. It has been proposed that DNA base damage generated by these agents is repaired mainly by base excision repair pathways (1) . This repair process is initiated by spontaneous depurination or DNA glycosylase-mediated hydrolytic cleavage at the N-glycosyl bond between the base and deoxyribose, resulting in the formation of an AP3 site. The spontaneous depurination rate was estimated at 10,000 bases per cell per day under physiological conditions by extrapolation of the data obtained upon release of radiolabeled bases from DNA at 70°C (2) . Recently, using a combination of an ARP and slot blot techniques (ASB assay), we directly demonstrated the spontaneous depurination rate under physiological conditions to be 1.5 AP sites per 106 nucleotides per day, which corresponds to ~9000 AP sites per cell per day (3) . These experiments suggest that spontaneous depurination is one of the most frequent promutagenic events in genomic DNA. Furthermore, direct release of bases is also induced by free radical attack of the deoxyribose (4) . These AP sites have to be repaired efficiently because of their potential cytotoxicity and mutagenicity (5) . To date, the kinetics of AP site repair have been studied in detail only in in vitro experiments with oligonucleotides and plasmids. The steady-state number of AP sites in genomic DNA has not been characterized because of technical problems related to sensitivity and specificity of existing methods. To better understand the steady state of AP sites at basal levels of base excision repair in vivo, we measured the amount of endogenous AP sites in genomic DNA extracted from various tissues of adult rats and human liver using the ASB assay. In addition, the endogenous AP sites were further characterized by the determination of cleavage sites to the AP sites in these genomic DNAs.


    Materials and Methods
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 
DNA Extraction
Six male F344 rats were obtained from Charles River Laboratories and maintained until they were ~7.5 months old. Rats were sacrificed after being anesthetized with metofane. Tissues and organs were quickly harvested and frozen at -80°C until DNA extraction. Eight human liver samples were provided by Dr. C. J. Omiecinski (University of Washington, Seattle, WA; Ref. 6 ). DNA was extracted by a procedure slightly modified from the method reported by Nakamura et al. (3) . Briefly, frozen tissues were thawed and homogenized in PBS with a Tehran homogenizer (Wheaton Instruments, Millville, NJ). After centrifugation at 2,000 x g for 10 min, the nuclear pellets were incubated in lysis buffer (Applied Biosystems) overnight at 4°C with proteinase K (500 mg/ml; Applied Biosystems). DNA was then extracted twice with a mixture of phenol, chloroform, and water and once with Sevag, followed by ethanol precipitation. The extracted DNA was incubated in PBS (pH 7.4) with a mixture of RNase and RNase A. After DNA precipitation with cold ethanol, the DNA pellet was resuspended in sterilized distilled water. The DNA solution was stored at -80°C for the ASB assay. The DNA extraction method used in this study was unlikely to have modified the original number of AP sites in genomic DNA from intact tissues, based on reextraction data of DNA highly exposed to methylmethane sulfonate.

ASB Assay
The AP site assay was performed by a procedure slightly modified from the method reported by Nakamura et al. (3) . Briefly, 15 µg of DNA in 150 µl of PBS were incubated with 1 mM ARP (Dojindo Laboratories, Kumamoto, Japan) at 37°C for 10 min. After precipitation using cold ethanol, DNA was resuspended in Tris-EDTA buffer. The DNA concentration was measured by a spectrophotometer, and the DNA solution was then prepared at 1.5 µg per 100 µl of Tris-EDTA buffer. Heat-denatured DNA was then immobilized on a NC membrane. The NC membrane was soaked with 5x SSC and then baked in a vacuum oven. The membrane was preincubated with 10 ml of Tris-HCl buffer containing BSA. The NC filter was then incubated in the same solution containing streptavidin-conjugated horseradish peroxidase (BioGenix) at room temperature for 40 min. After the NC membrane was rinsed, the enzymatic activity on the membrane was visualized by the use of enhanced chemiluminescence reagents (Amersham Corp.). The NC filter was then exposed to X-ray film, and the developed film was analyzed using an Ultrascan XL scanning densitometer.

Heat/Acid Treatment of Calf Thymus DNA
Calf thymus DNA was treated with 100 mM MX in 10 mM Tris-HCl buffer-KOH (pH 7.4) at 37°C for 2 h to reduce the original number of AP sites in calf thymus DNA (Sigma). The DNA was purified twice by ethanol precipitation, followed by resuspension in distilled water. The calf thymus DNA pretreated with MX was incubated with heat/acid buffer as described in a previous paper (3) for various periods of time.

AP Site Cleavage Assay
Regular AP Site Assay.
Fifteen µg of DNA in 135 µl of 10 mM Tris-HCl-KOH buffer (pH 7.5) containing 50 mM NaCl and 5 mM MgCl2 were incubated with 1 mM ARP at 37°C for 10 min, followed by the ASB assay described above.

5' Cleavage Assay.
Fifteen µg of DNA and 145 units of Escherichia coli Exo III (New England Biolabs) in 135 µl of 10 mM Tris-HCl-KOH buffer as described above were incubated at 37°C for 1 min, immediately followed by the ASB assay. The number of 3'-cleaved AP sites was calculated as the original number of AP sites minus the number of AP sites left after treatment with Exo III alone.

3' Cleavage Assay.
Fifteen µg of DNA, 10 mM EDTA, and 100 mM putrescine (Sigma) in 135 µl of 10 mM Tris-HCl-KOH buffer as described above were incubated at 37°C for 30 min, immediately followed by the ASB assay. The number of 5'-cleaved AP sites was calculated as the original number of AP sites minus the number of AP sites left after treatment with putrescine alone.

Detection of Residual AP Sites.
Fifteen µg of DNA and 145 units of Exo III in 110 µ1 of 10 mM Tris-HCl-KOH buffer as described above were incubated at 37°C for 1 min, immediately followed by the addition of a 1/10 volume of 100 mM EDTA. The sample was incubated with 100 mM putrescine in the reaction buffer at 37°C for 30 min, immediately followed by the ASB assay. Residual AP sites showed the number of uncleaved aldehydic lesions after the combination treatment of Exo III and putrescine.

Depurination Assay
Fifteen µg of DNA in 110 µl of PBS (pH 7.4) were incubated at 100°C for 20 min, followed by renaturation at room temperature for 1 h. After incubation with 100 mM putrescine, DNA was reacted with ARP, followed by the ASB assay. The number of heat-labile sites was calculated as the number of AP sites in DNA treated with heat buffer followed by putrescine minus the number of AP sites left after treatment with putrescine alone.

End III-sensitive Assay
Oxidative pyrimidine bases are repaired by End III, leaving AP sites on DNA backbone (5) . E. coli End III was kindly provided by Dr. Y. W. Kow (Emory University, Atlanta, GA). Fifteen µg of DNA, 1 mM EDTA, 100 mM NaCl, 100 mM putrescine, and E. coli End III (0.1 µg) in 135 µl of 10 mM Tris-HCl-KOH buffer as described above were incubated at 37°C for 30 min, immediately followed by the ASB assay. The number of End III-sensitive sites was calculated as number of AP sites in DNA treated with End III and putrescine minus the number of AP sites left after treatment with putrescine alone.


    Results and Discussion
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 
To better understand the formation and repair of AP sites resulting from base excision repair and spontaneous depurination/depyrimidination in vivo, we measured the number of endogenous AP sites in genomic DNA extracted from various tissues of adult rats and transplant-quality human liver using the ASB assay (3) . The number of endogenous AP sites varied widely between tissues (Fig. 1)Citation but not within tissues. The highest number of AP sites was detected in the brain, with 30 AP sites per 106 nucleotides, followed by the heart and colon. In contrast, rat liver, kidney, and lung consistently showed the lowest number of AP sites (8–9 AP sites per 106 nucleotides). The number of endogenous AP sites in human liver was comparable to that in rat liver. These data indicate that AP sites persist at 50,000–200,000 lesions per mammalian cell under normal physiological conditions. The steady-state number of AP sites in genomic DNA should reflect the balance between the formation and repair of the AP sites. Possible interpretations of the higher number of endogenous AP sites in the brain are as follows: (a) higher rate of depurination and/or endogenous DNA adduct formation, resulting in more AP sites; (b) higher activity of DNA glycosylase, inducing more AP sites; (c) lower activity of type II AP endonuclease, causing accumulation of AP sites; and (d) less efficiency of dRp-ase or ß-elimination, leaving 5'-nicked AP sites.



View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 1. Endogenous AP sites in rat and human tissues. DNA was extracted at 4°C from intact rat tissues and normal human livers, and the number of AP sites was measured using the ASB assay. A, typical X-ray film showing endogenous AP sites of rat tissues. DNA (including standard DNA samples) was loaded on a NC membrane (1.5 µg per slot). B, scanning densitometric data of endogenous AP sites in rat and human tissues. Columns, means from duplicate slots of five to eight individual samples; bars, SD.

 
The major process in the repair of AP sites is the type II AP endonuclease-/ß-pol-dependent pathway (7) . Type II AP endonuclease can recognize AP sites and incise the phosphodiester backbone immediately 5' to the lesions, leaving a 3'-hydroxyl group and 5'-AP site terminus (5) . The 5'-dRp is subsequently released, and the single nucleotide gap is filled. It has been demonstrated that significant amounts of type II AP endonuclease are present in the nucleus of mammalian cells (8) . Previously, we showed that the combination of ASB assay and type II AP endonuclease or NaOH induces 3' or 5' cleavage of AP sites, respectively (3) . To understand the activity of AP endonuclease and dRp-ase in vivo, we further optimized the AP site cleavage assay. In this experiment, we used Exo III as the type II AP endonuclease to identify 3'-cleavage of AP sites and putrescine to detect 5'-nicks (Fig. 2)Citation . To characterize this AP site cleavage assay, we incubated DNA that had been pretreated with MX to reduce the number of AP sites to 3.8 ± 0.5 AP sites per 106 nucleotides (mean ± SD) with heat and acid buffer. Various periods of heat/acid incubation induced 11, 47, 115, and 320 AP sites per 106 nucleotides. A single treatment of Exo III reduced the number of AP sites by 4–10 AP sites per 106 nucleotides in each DNA sample, regardless of the initial number present (Fig. 3)Citation . This reduction may be due to the combination of enzymatic incision on the 5' side by Exo III and nonspecific 3' cleavage of AP sites during incubation with Exo III. This nonspecific 3' cleavage precluded precise quantitation of the number of 3'-nicked AP sites in DNA with this assay. In contrast, putrescine treatment showed no reduction in the number of AP sites. After incubation with Exo III followed by putrescine, the number of AP sites was reduced to the original number of AP sites in calf thymus DNA pretreated with MX. The cleavage efficiency of AP sites by the combination of Exo III and putrescine was >99%.



View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 2. Scheme of AP site cleavage assay. To better understand the activities of type II AP endonuclease, as well as dRp-ase in vivo, we determined the existence of cleavages on the 5' or 3' side of AP sites in genomic DNA. Putrescine and Exo III (type II AP endonuclease) leave 3'-cleaved [(II)] and 5'-cleaved [(III)] AP sites, respectively. For intact AP sites [(I)] with no incision at the 3' and 5' sides of AP sites, the ASB assay can theoretically detect the original number of AP sites after treatment with either Exo III [(III)] or putrescine [(II)] because AP sites remain on the DNA backbone after incision at either side of the phosphodiester bond adjacent to the AP site. However, the combination of Exo III and putrescine cleaves at both 3' and 5' sides of the AP site [(IV)], resulting in release of the AP site from the DNA backbone [(V)]. Such released AP sites are not detected by this assay. On the basis of the number of AP sites left on the DNA backbone after this cleavage reaction, the number of 5'- and 3'-cleaved AP sites can be estimated. If 5'-cleaved AP sites [(VI)] are present in DNA, the putrescine single treatment can release the 5'-nicked AP sites by 3'-excision of the AP sites [(VII) and (VIII)]. Likewise, 3'-nicked AP sites [(IX)] in DNA can be released by 5'-excision using Exo III [(X) and (XI)].

 


View larger version (28K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 3. AP site cleavage assay of calf thymus DNA treated with heat/acid buffer. To validate the AP site cleavage assay, we examined the effects of Exo III and putrescine on intact AP sites induced in calf thymus DNA. The original number of AP sites in calf thymus DNA was reduced by MX (CTD/MX). DNA was then incubated in heat/acid buffer for different lengths of time to introduce different numbers of intact AP sites (-/-; Ref. 9 ). DNA was incubated with Exo III and/or putrescine, and the number of remaining AP sites in calf thymus DNA was measured by the ASB assay [Exo III only (Exo III/-), Exo III plus putrescine (Exo III/P), and putrescine only (-/P)]. Columns, means from duplicate slots of three individual samples; bars, SD. A, AP site cleavage assay of DNA containing 115 AP sites per 106 nucleotides. B, summary of AP site cleavage assay of DNA containing different numbers of AP sites.

 
We applied this assay to genomic DNA extracted from rat and human tissues to characterize endogenous AP sites. The fractions of intact and cleaved AP sites, and residual aldehydic lesions are summarized in Fig. 4Citation . Rat and human tissue DNA were incubated with Exo III followed by putrescine to examine whether detected lesions were actual AP sites. After 5' and 3' cleavage of AP sites, 1.5–2.2 residual aldehydic lesions per 106 nucleotides were detected. These data indicate that the ASB assay correctly measures endogenous AP sites. The residual lesions may be due to limitations of enzyme reactions in the AP site cleavage assay as well as to the presence of endogenous aldehydic base lesions such as formyluracil (10) . In addition, a combined fraction of 3'-cleaved and intact AP sites was detected at ~2–3 lesions per 106 nucleotides in different tissues, which is ~1/3–1/10 of the total number of endogenous AP sites. To examine the number of 5'-cleaved AP sites, we incubated DNA with putrescine. The reduction of AP sites by putrescine (the original number of AP sites minus the number of AP sites left after putrescine incubation) represented the number of 5'-cleaved AP sites. In contrast to calf thymus DNA pretreated with heat/acid buffer, genomic DNA treated with putrescine had a markedly decreased number of AP sites. These data indicate that approximately two-thirds or more of the endogenous AP sites are already cleaved on the 5' side of AP sites in vivo.



View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 4. Summary of AP site cleavage assay of rat and human tissue DNA. The original number of AP sites as described in the legend to Fig. 1BCitation consisted of 5'-cleaved, 3'-cleaved, intact AP sites, and residual aldehydic lesions. The number of 5'-cleaved AP sites was calculated as the original number of AP sites minus the number of AP sites left after treatment with putrescine alone. The combined fraction of 3'-cleaved and intact AP sites was the difference between putrescine treatment and the combination treatment of Exo III and putrescine. Residual AP sites showed the number of uncleaved aldehydic lesions.

 
After 5' cleavage of the AP sites by type II AP endonuclease, the incised AP sites subsequently have to be released from the DNA backbone via the excision of 5'-dRp residues. This releasing process is possibly performed by dRp-ase via hydrolytic reaction (11) or ß-elimination (12) or via an endonucleolytic enzyme that incises downstream of 5'-dRp moieties (13) . It has been demonstrated that Xenopus and human ß-pol release 5'-dRp by ß-elimination (14) . Using repair patch size either in ß-pol-null or -proficient cells, it has been demonstrated that a single gap repair pathway was predominant in ß-pol-proficient cells but not in ß-pol-null cells (15) . In addition, the interaction between human AP endonuclease and ß-pol accelerates the release of 5'-dRp residues in vitro (16) . However, the repair efficiency of 5'-dRp moieties has not been well characterized in cells or in vivo. Using yeast cell-free extracts, the processing of the 5'-dRp moieties has been found to be a rate-limiting step during base excision repair of uracil-containing DNA (17) . Furthermore, the catalytic efficiency of ß-pol to remove 5'-dRp was examined (18) . Interestingly, the Kcat of 5'- dRp-ase activity of ß-pol was ~100-fold lower than the Kcat of AP endonuclease. This study demonstrates a clear persistence of 5'-incised AP sites in rat and human tissues. These data suggest that incision by AP endonuclease and the subsequent release of 5'-dRp residues may not be efficiently linked at a basal level in vivo and that the repair process of 5'-dRp may be one of the rate-limiting steps in base excision repair.

In the previous study (3) , we demonstrated that spontaneous depurination occurred at 1.5 AP sites per 106 nucleotides per day under physiological conditions. To test whether heat-labile DNA adducts such as N3- and N7-alkyl purines were the source of the higher number of endogenous AP sites in brain, a depurination assay was performed in brain and liver DNA. However, no difference was observed in brain and liver (data not shown). Therefore, the steady state of endogenous AP sites may not be due to labile base lesions. One of the most important and abundant endogenous DNA lesions is oxidative DNA base damage. It has been reported that the steady state of 5-hydroxycytosine in rat brain is ~2-fold higher than that in rat liver (19) . Such oxidative pyrimidine bases are repaired by End III, leaving AP sites on the DNA backbone. To examine whether oxidative stress could be related to the steady-state number of AP sites in DNA, End III-sensitive sites were quantitated using the combination of the ASB assay and E. coli End III. The number of End III-sensitive sites was three times higher in brain (14 lesions per 106 nucleotides) compared to other tissues (4–5 lesions per 106 nucleotides). Recently, the human homologue of the End III (hNTH1) gene has been cloned and characterized (20) . The mRNA expression of this gene varies between organs in a pattern that corresponds with the number of endogenous AP sites (20) . Most DNA glycosylases involved in the repair of oxidized bases possess AP lyase activity, which cleaves the 3' side of AP sites. Therefore, endogenous 5' AP sites would not be derived from the cleavages of oxidative bases by such DNA glycosylases. A preliminary experiment showed that hydrogen peroxide with FeSO4 directly induced 5'-cleaved AP sites in calf thymus DNA without any enzymes (data not shown). These studies suggest that oxidative stress might be one of the factors responsible for the steady state of AP sites with 5' cleavage.

We originally expected to find low numbers of endogenous AP sites in genomic DNA because of their toxicity and mutagenicity. However, this study shows that the steady state of AP sites is ~1 lesion per 105 nucleotides in genomic DNA. Although AP sites are constantly being repaired, the fraction of AP sites that escapes repair is likely to contribute to mutations, chromosome aberrations, and transcription errors that may be associated with spontaneous age-related diseases such as cancer and degenerative disorders.


    ACKNOWLEDGMENTS
 
We thank C. J. Omiecinski, C. Hassett, and K. Thummel for providing the human liver samples; Y. W. Kow for providing End III; and A. Lindstorm for providing F344 rats. We also thank E. C. Kidd, P. B. Upton, K. S. McDorman, and N. Scheller for assisting in the preparation of the manuscript and for technical assistance. The critical reading of the manuscript by M. D. Topal, S. A. Leadon, W. K. Kaufmann, A-J. L. Ham, A. P-H. Lin, and D. K. La is acknowledged.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Funded in part by National Institute of Environmental Health Sciences Superfund Basic Research Program Grant P42-ES05948. Back

2 To whom requests for reprints should be addressed, at Department of Environmental Sciences and Engineering, The University of North Carolina, CB 7400, Chapel Hill, NC 27599-7400. Back

3 The abbreviations used are: AP, apurinic/apyrimidinic; ARP, aldehyde-reactive probe; ASB, ARP-slot blot; NC, nitrocellulose; MX, methoxyamine; Exo III, exonuclease III; End III, endonuclease III; 5'-dRp, deoxyribose-5-phosphate; dRp-ase, 5'-deoxyribophosphodiesterase; ß-pol, polymerase ß. Back

Received 2/ 1/99. Accepted 4/15/99.


    REFERENCES
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 

  1. Lindahl T. Instability and decay of the primary structure of DNA. Nature (Lond.), 362: 709-715, 1993.[Medline]
  2. Lindahl T., Nyberg B. Rate of depurination of native deoxyribonucleic acid. Biochemistry, 11: 3610-3618, 1972.[Medline]
  3. Nakamura J., Walker V. E., Upton P. B., Chiang S-Y., Kow Y. W., Swenberg J. A. Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions. Cancer Res., 58: 222-225, 1998.[Abstract/Free Full Text]
  4. Breen A. P., Murphy J. A. Reactions of oxyl radicals with DNA. Free Radical Biol. Med., 18: 1033-1077, 1995.[Medline]
  5. Demple B., Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Annu. Rev. Biochem., 63: 915-948, 1994.[Medline]
  6. Hassett C., Lin J., Carty C. L., Laurenzana E. M., Omiecinski C. J. Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch. Biochem. Biophys., 337: 275-283, 1997.[Medline]
  7. Dianov G., Price A., Lindahl T. Generation of single-nucleotide repair patches following excision of uracil residues from DNA. Mol. Cell Biol., 12: 1605-1612, 1992.[Abstract/Free Full Text]
  8. Demple B., Herman T., Chen D. S. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc. Natl. Acad. Sci. USA, 88: 11450-11454, 1991.[Abstract/Free Full Text]
  9. Behmoaras T., Toulme J. J., Helene C. A tryptophan-containing peptide recognizes and cleaves DNA at apurinic sites. Nature (Lond.), 292: 858-859, 1981.[Medline]
  10. Ide H., Akamatsu K., Kimura Y., Michiue K., Makino K., Asaeda A., Takamori Y., Kubo K. Synthesis and damage specificity of a novel probe for the detection of abasic sites in DNA. Biochemistry, 32: 8276-8283, 1993.[Medline]
  11. Franklin W. A., Lindahl T. DNA deoxyribophosphodiesterase. EMBO J., 7: 3617-3622, 1988.[Medline]
  12. Aburatani H., Hippo Y., Ishida T., Takashima R., Matsuba C., Kodama T., Takao M., Yasui A., Yamamoto K., Asano M. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res., 57: 2151-2156, 1997.[Abstract/Free Full Text]
  13. Klungland A., Lindahl T. Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1). EMBO J., 16: 3341-3348, 1997.[Medline]
  14. Matsumoto Y., Kim K. Excision of deoxyribose phosphate residues by DNA polymerase ß during DNA repair. Science (Washington DC), 269: 699-702, 1995.[Abstract/Free Full Text]
  15. Fortini P., Pascucci B., Parlanti E., Sobol R. W., Wilson S. H., Dogliotti E. Different DNA polymerases are involved in the short- and long-patch base excision repair in mammalian cells. Biochemistry, 37: 3575-3580, 1998.[Medline]
  16. Bennett R. A., Wilson D. M., III, Wong D., Demple B. Interaction of human apurinic endonuclease and DNA polymerase ß in the base excision repair pathway. Proc. Natl. Acad. Sci. USA, 94: 7166-7169, 1997.[Abstract/Free Full Text]
  17. Wang Z., Wu X., Friedberg E. C. Molecular mechanism of base excision repair of uracil-containing DNA in yeast cell-free extracts. J. Biol. Chem., 272: 24064-24071, 1997.[Abstract/Free Full Text]
  18. Srivastava D. K., Berg B. J., Prasad R., Molina J. T., Beard W. A., Tomkinson A. E., Wilson S. H. Mammalian abasic site base excision repair. Identification of the reaction sequence and rate-determining steps. J. Biol. Chem., 273: 21203-21209, 1998.[Abstract/Free Full Text]
  19. Wagner J. R., Hu C. C., Ames B. N. Endogenous oxidative damage of deoxycytidine in DNA. Proc. Natl. Acad. Sci. USA, 89: 3380-3384, 1992.[Abstract/Free Full Text]
  20. Aspinwall R., Rothwell D. G., Roldan-Arjona T., Anselmino C., Ward C. J., Cheadle J. P., Sampson J. R., Lindahl T., Harris P. C., Hickson I. D. Cloning and characterization of a functional human homolog of Escherichia coli endonuclease III. Proc. Natl. Acad. Sci. USA, 94: 109-114, 1997.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W. A. Beard, D. D. Shock, V. K. Batra, L. C. Pedersen, and S. H. Wilson
DNA Polymerase {beta} Substrate Specificity: SIDE CHAIN MODULATION OF THE "A-RULE"
J. Biol. Chem., November 13, 2009; 284(46): 31680 - 31689.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Summer, O. Li, Q. Bao, L. Zhan, S. Peter, P. Sathiyanathan, D. Henderson, T. Klonisch, S. D. Goodman, and P. Droge
HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy
Nucleic Acids Res., July 1, 2009; 37(13): 4371 - 4384.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Ma, V. Panduri, J. F. Sterling, B. Van Houten, D. A. Gordenin, and M. A. Resnick
The Transition of Closely Opposed Lesions to Double-Strand Breaks during Long-Patch Base Excision Repair Is Prevented by the Coordinated Action of DNA Polymerase {delta} and Rad27/Fen1
Mol. Cell. Biol., March 1, 2009; 29(5): 1212 - 1221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Xiao, Y. Su, R. C. M. Simmen, and F. A. Simmen
Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase
Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G868 - G876.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. G. Woods, A. M. Burns, B. U. Bradford, P. K. Ross, O. Kosyk, J. A. Swenberg, M. L. Cunningham, and I. Rusyn
WY-14,643 Induced Cell Proliferation and Oxidative Stress in Mouse Liver are Independent of NADPH Oxidase
Toxicol. Sci., August 1, 2007; 98(2): 366 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Fiala and Z. Suo
Sloppy Bypass of an Abasic Lesion Catalyzed by a Y-family DNA Polymerase
J. Biol. Chem., March 16, 2007; 282(11): 8199 - 8206.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Wang, C. C. Shupenko, L. F. Melo, and P. R. Strauss
DNA Repair Protein Involved in Heart and Blood Development
Mol. Cell. Biol., December 1, 2006; 26(23): 9083 - 9093.
[Abstract] [Full Text] [PDF]


Home page
Radiat Prot DosimetryHome page
L. B. Smilenov, E. J. Hall, W. M. Bonner, and O. A. Sedelnikova
A microbeam study of DNA double-strand breaks in bystander primary human fibroblasts
Radiat Prot Dosimetry, December 1, 2006; 122(1-4): 256 - 259.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. D. Chastain II, J. Nakamura, J. Swenberg, and D. Kaufman
Nonrandom AP site distribution in highly proliferative cells
FASEB J, December 1, 2006; 20(14): 2612 - 2614.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. L. Powell, O. Kosyk, P. K. Ross, R. Schoonhoven, G. Boysen, J. A. Swenberg, A. N. Heinloth, G. A. Boorman, M. L. Cunningham, R. S. Paules, et al.
Phenotypic Anchoring of Acetaminophen-Induced Oxidative Stress with Gene Expression Profiles in Rat Liver
Toxicol. Sci., September 1, 2006; 93(1): 213 - 222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Jin, W. S. May, F. Gao, T. Flagg, and X. Deng
Bcl2 Suppresses DNA Repair by Enhancing c-Myc Transcriptional Activity
J. Biol. Chem., May 19, 2006; 281(20): 14446 - 14456.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Takeuchi, T. Ruike, R.-i. Nakamura, K. Shimanouchi, Y. Kanai, Y. Abe, A. Ihara, and K. Sakaguchi
Drosophila DNA Polymerase {zeta} Interacts with Recombination Repair Protein 1, the Drosophila Homologue of Human Abasic Endonuclease 1
J. Biol. Chem., April 28, 2006; 281(17): 11577 - 11585.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. Seiple, P. Jaruga, M. Dizdaroglu, and J. T. Stivers
Linking uracil base excision repair and 5-fluorouracil toxicity in yeast
Nucleic Acids Res., January 10, 2006; 34(1): 140 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Sung, M. S. DeMott, and B. Demple
Long-patch Base Excision DNA Repair of 2-Deoxyribonolactone Prevents the Formation of DNA-Protein Cross-links with DNA Polymerase {beta}
J. Biol. Chem., November 25, 2005; 280(47): 39095 - 39103.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y.-C. Jeong, J. Nakamura, P. B. Upton, and J. A. Swenberg
Pyrimido[1,2-a]-purin-10(3H)-one, M1G, is less prone to artifact than base oxidation
Nucleic Acids Res., November 10, 2005; 33(19): 6426 - 6434.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Ulrich, K. Curtin, J. D. Potter, J. Bigler, B. Caan, and M. L. Slattery
Polymorphisms in the Reduced Folate Carrier, Thymidylate Synthase, or Methionine Synthase and Risk of Colon Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2509 - 2516.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. M. Ulrich
Nutrigenetics in Cancer Research--Folate Metabolism and Colorectal Cancer
J. Nutr., November 1, 2005; 135(11): 2698 - 2702.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Madhusudan, F. Smart, P. Shrimpton, J. L. Parsons, L. Gardiner, S. Houlbrook, D. C. Talbot, T. Hammonds, P. A. Freemont, M. J. E. Sternberg, et al.
Isolation of a small molecule inhibitor of DNA base excision repair
Nucleic Acids Res., August 19, 2005; 33(15): 4711 - 4724.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. F. Harrison, S. B. Hollensworth, D. R. Spitz, W. C. Copeland, G. L. Wilson, and S. P. LeDoux
Oxidative stress-induced apoptosis in neurons correlates with mitochondrial DNA base excision repair pathway imbalance
Nucleic Acids Res., August 17, 2005; 33(14): 4660 - 4671.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Sossou, C. Flohr-Beckhaus, I. Schulz, F. Daboussi, B. Epe, and J. P. Radicella
APE1 overexpression in XRCC1-deficient cells complements the defective repair of oxidative single strand breaks but increases genomic instability
Nucleic Acids Res., January 12, 2005; 33(1): 298 - 306.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. G. Georgakilas, P. V. Bennett, D. M. Wilson III, and B. M. Sutherland
Processing of bistranded abasic DNA clusters in {gamma}-irradiated human hematopoietic cells
Nucleic Acids Res., October 19, 2004; 32(18): 5609 - 5620.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Huamani, C. A. McMahan, D. C. Herbert, R. Reddick, J. R. McCarrey, M. I. MacInnes, D. J. Chen, and C. A. Walter
Spontaneous Mutagenesis Is Enhanced in Apex Heterozygous Mice
Mol. Cell. Biol., September 15, 2004; 24(18): 8145 - 8153.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Zielinska-Park, J. Nakamura, J. A. Swenberg, and M. D. Aitken
Aldehydic DNA lesions in calf thymus DNA and HeLa S3 cells produced by bacterial quinone metabolites of fluoranthene and pyrene
Carcinogenesis, September 1, 2004; 25(9): 1727 - 1733.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Wong and B. Demple
Modulation of the 5'-Deoxyribose-5-phosphate Lyase and DNA Synthesis Activities of Mammalian DNA Polymerase {beta} by Apurinic/Apyrimidinic Endonuclease 1
J. Biol. Chem., June 11, 2004; 279(24): 25268 - 25275.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
R. De Bont and N. van Larebeke
Endogenous DNA damage in humans: a review of quantitative data
Mutagenesis, May 1, 2004; 19(3): 169 - 185.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Raffoul, D. C. Cabelof, J. Nakamura, L. B. Meira, E. C. Friedberg, and A. R. Heydari
Apurinic/Apyrimidinic Endonuclease (APE/REF-1) Haploinsufficient Mice Display Tissue-specific Differences in DNA Polymerase {beta}-Dependent Base Excision Repair
J. Biol. Chem., April 30, 2004; 279(18): 18425 - 18433.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
B. Ribar, T. Izumi, and S. Mitra
The major role of human AP-endonuclease homolog Apn2 in repair of abasic sites in Schizosaccharomyces pombe
Nucleic Acids Res., January 2, 2004; 32(1): 115 - 126.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Zurer, L. J. Hofseth, Y. Cohen, M. Xu-Welliver, S. P. Hussain, C. C. Harris, and V. Rotter
The role of p53 in base excision repair following genotoxic stress
Carcinogenesis, January 1, 2004; 25(1): 11 - 19.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Kokoska, S. D. McCulloch, and T. A. Kunkel
The Efficiency and Specificity of Apurinic/Apyrimidinic Site Bypass by Human DNA Polymerase {eta} and Sulfolobus solfataricus Dpo4
J. Biol. Chem., December 12, 2003; 278(50): 50537 - 50545.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Guillet and S. Boiteux
Origin of Endogenous DNA Abasic Sites in Saccharomyces cerevisiae
Mol. Cell. Biol., November 15, 2003; 23(22): 8386 - 8394.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Barbin, H. Ohgaki, J. Nakamura, M. Kurrer, P. Kleihues, and J. A. Swenberg
Endogenous Deoxyribonucleic Acid (DNA) Damage in Human Tissues: A Comparison of Ethenobases with Aldehydic DNA Lesions
Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1241 - 1247.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
K. L. Meadows, B. Song, and P. W. Doetsch
Characterization of AP lyase activities of Saccharomyces cerevisiae Ntg1p and Ntg2p: implications for biological function
Nucleic Acids Res., October 1, 2003; 31(19): 5560 - 5567.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Wong, M. S. DeMott, and B. Demple
Modulation of the 3'->5'-Exonuclease Activity of Human Apurinic Endonuclease (Ape1) by Its 5'-incised Abasic DNA Product
J. Biol. Chem., September 19, 2003; 278(38): 36242 - 36249.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
L. Calderon-Garciduenas, R. R. Maronpot, R. Torres-Jardon, C. Henriquez-Roldan, R. Schoonhoven, H. Acuna-Ayala, A. Villarreal-Calderon, J. Nakamura, R. Fernando, W. Reed, et al.
DNA Damage in Nasal and Brain Tissues of Canines Exposed to Air Pollutants Is Associated with Evidence of Chronic Brain Inflammation and Neurodegeneration
Toxicol Pathol, August 1, 2003; 31(5): 524 - 538.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
P.-H. Lin, J. Nakamura, S. Yamaguchi, S. Asakura, and J. A. Swenberg
Aldehydic DNA lesions induced by catechol estrogens in calf thymus DNA
Carcinogenesis, June 1, 2003; 24(6): 1133 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Kamiya
Mutagenic potentials of damaged nucleic acids produced by reactive oxygen/nitrogen species: approaches using synthetic oligonucleotides and nucleotides: SURVEY AND SUMMARY
Nucleic Acids Res., January 15, 2003; 31(2): 517 - 531.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. R. Silber, M. S. Bobola, A. Blank, K. D. Schoeler, P. D. Haroldson, M. B. Huynh, and D. D. Kolstoe
The Apurinic/Apyrimidinic Endonuclease Activity of Ape1/Ref-1 Contributes to Human Glioma Cell Resistance to Alkylating Agents and Is Elevated by Oxidative Stress
Clin. Cancer Res., September 1, 2002; 8(9): 3008 - 3018.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. G. Georgakilas, P. V. Bennett, and B. M. Sutherland
High efficiency detection of bi-stranded abasic clusters in {gamma}-irradiated DNA by putrescine
Nucleic Acids Res., July 1, 2002; 30(13): 2800 - 2808.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. Ulrich, J. Bigler, R. Bostick, L. Fosdick, and J. D. Potter
Thymidylate Synthase Promoter Polymorphism, Interaction with Folate Intake, and Risk of Colorectal Adenomas
Cancer Res., June 1, 2002; 62(12): 3361 - 3364.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. W. Sobol, D. E. Watson, J. Nakamura, F. M. Yakes, E. Hou, J. K. Horton, J. Ladapo, B. Van Houten, J. A. Swenberg, K. R. Tindall, et al.
Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress
PNAS, May 14, 2002; 99(10): 6860 - 6865.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z. Fan, P. J. Beresford, D. Zhang, and J. Lieberman
HMG2 Interacts with the Nucleosome Assembly Protein SET and Is a Target of the Cytotoxic T-Lymphocyte Protease Granzyme A
Mol. Cell. Biol., April 15, 2002; 22(8): 2810 - 2820.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. M. Flaherty, M. M. Monick, and G. W. Hunninghake
AP Endonucleases and the Many Functions of Ref-1
Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 664 - 667.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Wilstermann and N. Osheroff
Base Excision Repair Intermediates as Topoisomerase II Poisons
J. Biol. Chem., November 30, 2001; 276(49): 46290 - 46296.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Fung, R. A. O. Bennett, and B. Demple
Key Role of a Downstream Specificity Protein 1 Site in Cell Cycle-regulated Transcription of the AP Endonuclease Gene APE1/APEX in NIH3T3 Cells
J. Biol. Chem., November 2, 2001; 276(45): 42011 - 42017.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P.-H. Lin, J. Nakamura, S. Yamaguchi, P. B. Upton, D. K. La, and J. A. Swenberg
Oxidative damage and direct adducts in calf thymus DNA induced by the pentachlorophenol metabolites, tetrachlorohydroquinone and tetrachloro-1,4-benzoquinone
Carcinogenesis, April 1, 2001; 22(4): 627 - 634.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P.-H. Lin, J. Nakamura, S. Yamaguchi, D. K. La, P. B. Upton, and J. A. Swenberg
Induction of direct adducts, apurinic/apyrimidinic sites and oxidized bases in nuclear DNA of human HeLa S3 tumor cells by tetrachlorohydroquinone
Carcinogenesis, April 1, 2001; 22(4): 635 - 639.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. R. Kelley, L. Cheng, R. Foster, R. Tritt, J. Jiang, J. Broshears, and M. Koch
Elevated and Altered Expression of the Multifunctional DNA Base Excision Repair and Redox Enzyme Ape1/ref-1 in Prostate Cancer
Clin. Cancer Res., April 1, 2001; 7(4): 824 - 830.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
M. N. Rios-Blanco, T. H. Faller, J. Nakamura, W. Kessler, P. E. Kreuzer, A. Ranasinghe, J. G. Filser, and J. A. Swenberg
Quantitation of DNA and hemoglobin adducts and apurinic/apyrimidinic sites in tissues of F344 rats exposed to propylene oxide by inhalation
Carcinogenesis, November 1, 2000; 21(11): 2011 - 2018.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Sabourin and N. Osheroff
Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesions
Nucleic Acids Res., May 1, 2000; 28(9): 1947 - 1954.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. J. Marnett
Oxyradicals and DNA damage
Carcinogenesis, March 1, 2000; 21(3): 361 - 370.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Nakamura, D. K. La, and J. A. Swenberg
5'-Nicked Apurinic/Apyrimidinic Sites Are Resistant to beta -Elimination by beta -Polymerase and Are Persistent in Human Cultured Cells after Oxidative Stress
J. Biol. Chem., February 25, 2000; 275(8): 5323 - 5328.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. K. Horton, R. Prasad, E. Hou, and S. H. Wilson
Protection against Methylation-induced Cytotoxicity by DNA Polymerase beta -Dependent Long Patch Base Excision Repair
J. Biol. Chem., January 21, 2000; 275(3): 2211 - 2218.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Atamna, I. Cheung, and B. N. Ames
A method for detecting abasic sites in living cells: Age-dependent changes in base excision repair
PNAS, January 18, 2000; 97(2): 686 - 691.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
S.H. WILSON, R.W. SOBOL, W.A. BEARD, J.K. HORTON, R. PRASAD, and B.J. VANDE BERG
DNA Polymerase {beta} and Mammalian Base Excision Repair
Cold Spring Harb Symp Quant Biol, January 1, 2000; 65(0): 143 - 156.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Ranalli, M. S. DeMott, and R. A. Bambara
Mechanism Underlying Replication Protein A Stimulation of DNA Ligase I
J. Biol. Chem., January 11, 2002; 277(3): 1719 - 1727.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, J.
Right arrow Articles by Swenberg, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, J.
Right arrow Articles by Swenberg, J. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online